These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1333 related items for PubMed ID: 14681504

  • 1. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
    McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.
    N Engl J Med; 2003 Dec 18; 349(25):2387-98. PubMed ID: 14681504
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ.
    N Engl J Med; 1996 Aug 22; 335(8):533-9. PubMed ID: 8684407
    [Abstract] [Full Text] [Related]

  • 3. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
    McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J.
    N Engl J Med; 1998 Feb 26; 338(9):557-63. PubMed ID: 9475762
    [Abstract] [Full Text] [Related]

  • 4. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ, Miner M.
    Clin Ther; 2007 Jan 26; 29(1):17-25. PubMed ID: 17379044
    [Abstract] [Full Text] [Related]

  • 5. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R, Thalmann G, Reich O, Steif CG.
    Aktuelle Urol; 2004 Sep 26; 35(5):339-42. PubMed ID: 15383991
    [No Abstract] [Full Text] [Related]

  • 6. Finasteride in benign prostatic hyperplasia.
    Verhamme KM, Bosch RJ, Sturkenboom MC.
    N Engl J Med; 2004 Mar 25; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract] [Full Text] [Related]

  • 7. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA, McVary KT.
    Int J Impot Res; 2008 Dec 25; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [Abstract] [Full Text] [Related]

  • 8. Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.
    Crawford ED, Wilson SS, McConnell JD, Slawin KM, Lieber MC, Smith JA, Meehan AG, Bautista OM, Noble WR, Kusek JW, Nyberg LM, Roehrborn CG, MTOPS RESEARCH Group.
    J Urol; 2006 Apr 25; 175(4):1422-6; discussion 1426-7. PubMed ID: 16516013
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA, McConnell JD, Roehrborn CG, Meehan AG, Lee MW, Noble WR, Kusek JW, Nyberg LM, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.
    J Urol; 2006 Jan 25; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [Abstract] [Full Text] [Related]

  • 10. Finasteride for benign prostatic hyperplasia.
    Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ.
    Cochrane Database Syst Rev; 2010 Oct 06; 2010(10):CD006015. PubMed ID: 20927745
    [Abstract] [Full Text] [Related]

  • 11. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
    Bogdanov AB, Luk'ianov IV, Veliev EI.
    Urologiia; 2006 Oct 06; (5):59-63. PubMed ID: 17444154
    [Abstract] [Full Text] [Related]

  • 12. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B, Gratzke C, Weidlich P, Seitz M, Reich O, Stief CG.
    MMW Fortschr Med; 2007 Aug 16; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [Abstract] [Full Text] [Related]

  • 13. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct 31; 144(44):56. PubMed ID: 12494605
    [No Abstract] [Full Text] [Related]

  • 14. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H, Hux M, Brisson M, Bernard L, Nickel JC.
    Can J Urol; 2004 Aug 31; 11(4):2327-40. PubMed ID: 15380054
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.
    Fwu CW, Eggers PW, Kaplan SA, Kirkali Z, Lee JY, Kusek JW.
    J Urol; 2013 Jul 31; 190(1):187-93. PubMed ID: 23357210
    [Abstract] [Full Text] [Related]

  • 16. [Drug therapy for benign prostatic syndrome (BPS)].
    Berges R.
    Aktuelle Urol; 2006 Sep 31; 37(5):351-62. PubMed ID: 17004180
    [Abstract] [Full Text] [Related]

  • 17. Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
    MacDonald R, Wilt TJ, Howe RW.
    BJU Int; 2004 Dec 31; 94(9):1263-70. PubMed ID: 15610102
    [Abstract] [Full Text] [Related]

  • 18. Medical management of benign prostatic hyperplasia--are two drugs better than one?
    Vaughan ED.
    N Engl J Med; 2003 Dec 18; 349(25):2449-51. PubMed ID: 14681512
    [No Abstract] [Full Text] [Related]

  • 19. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
    Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW.
    J Urol; 2014 Jun 18; 191(6):1828-34. PubMed ID: 24342143
    [Abstract] [Full Text] [Related]

  • 20. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.
    Johnson TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, Roehrborn CG, Medical Therapy of Prostatic Symptoms Research Group.
    J Urol; 2007 Nov 18; 178(5):2045-50; discussion 2050-1. PubMed ID: 17869295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.